All About Multiple Sclerosis

More MS news articles for December 2002

Individuals diagnosed with multiple sclerosis and have a history of pathological laughing and/or crying (pseudobulbar affect).

[I cannot find any reference to the actual name of this trial drug.]

A clinical research study to assess the safety and effectiveness of a study drug which may alleviate the symptoms of pathological laughing and/or crying (pseudobulbar affect) in individuals with multiple sclerosis (MS).

Inclusion Criteria:

Exclusion Criteria: Neurologists from the following locations will be participating and recruiting from within their communities: If you are interested in learning more about this study or becoming a participant, please contact:

© Copyright 2002 Multiple Sclerosis Foundation